Leif Niclas Fredrik Löwgren
Director/Board Member at Omnivation AB
Leif Niclas Fredrik Löwgren active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Omnivation AB | Director/Board Member | - | - |
Career history of Leif Niclas Fredrik Löwgren
Former positions of Leif Niclas Fredrik Löwgren
| Companies | Position | Start | End |
|---|---|---|---|
| GRUVAKTIEBOLAGET VISCARIA | Director/Board Member | - | 14/05/2019 |
| NEXTCELL PHARMA AB | Director/Board Member | 01/01/2017 | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Director/Board Member | 01/01/2017 | - |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Director/Board Member | - | - |
Training of Leif Niclas Fredrik Löwgren
| University of Stockholm | Masters Business Admin |
Statistics
International
| Sweden | 7 |
Operational
| Director/Board Member | 5 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GRUVAKTIEBOLAGET VISCARIA | Non-Energy Minerals |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| NEXTCELL PHARMA AB | Health Technology |
| Private companies | 2 |
|---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Omnivation AB |
